Myrobalan Therapeutics

Myrobalan Therapeutics is determined to develop novel oral medications to reverse the underlying damage associated with neurodegenerative, demyelinating, and neuropsychiatric disorders. This oral approach offers an advantage over traditional treatments for neurological conditions, as they are typically easier to administer and can improve patient compliance compared to injectable or other invasive procedures normally required for some of the currently effective treatments. Their state-of-the-art medicinal chemistry platforms and use of translatable disease models and clinical biomarkers increases their probability of success. Determining the critical overlapping mechanisms underlying diseases with unmet needs allows Myrobalan to develop therapies with broader use.

Jobs: